Monoclonal Antibody Capture and Analysis Using Porous Membranes Containing Immobilized Peptide Mimotopes

Anal Chem. 2018 Oct 16;90(20):12161-12167. doi: 10.1021/acs.analchem.8b03183. Epub 2018 Sep 25.

Abstract

Rapid, convenient methods for monoclonal antibody (mAb) isolation are critical for determining the concentrations of therapeutic mAbs in human serum. This work uses porous nylon membranes modified with a HER2 peptide mimotope, KGSGSGSQLGPYELWELSH (KH19), for rapid affinity capture of Herceptin, a mAb used to treat breast cancer. Covalent linking of KH19 to poly(acrylic acid)-containing films in porous nylon leads to a Herceptin-binding capacity of 10 mg per mL of membrane and allows selective Herceptin capture from diluted (1:3) human serum in 5 min. Liquid chromatography-mass spectrometry demonstrates the high purity of eluted Herceptin. Moreover, the fluorescence intensity of the protein eluted from membranes increases linearly with the amount of Herceptin spiked in loading solutions containing diluted (1:3) human serum. These results demonstrate the promise of mimotope-modified membranes for Herceptin analysis that does not require secondary antibodies or derivatization with fluorescent labels. Thus, mimotope-containing membranes may form part of a simple benchtop analysis system for assessing the concentrations of therapeutic mAbs.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Adsorption
  • Humans
  • Immobilized Proteins / chemistry*
  • Nylons / chemistry
  • Particle Size
  • Peptide Fragments / chemistry*
  • Porosity
  • Receptor, ErbB-2 / chemistry*
  • Surface Properties
  • Trastuzumab / analysis*
  • Trastuzumab / blood
  • Trastuzumab / isolation & purification*

Substances

  • Immobilized Proteins
  • Nylons
  • Peptide Fragments
  • ERBB2 protein, human
  • Receptor, ErbB-2
  • Trastuzumab